Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Biphenotypic, Acute 2Leukemia 2Colorectal Neoplasms 1

Interventions

Filgrastim 9Cytarabine 9fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 6Whole-Body Irradiation 5Granulocyte Colony-Stimulating Factor 5Cladribine 5Mitoxantrone 4Methotrexate 4Cyclophosphamide 4Melphalan 3Injections 3Cyclosporine 3Biopsy 3venetoclax 2revumenib 2pegylated granulocyte colony-stimulating factor 2X-Rays 2Trimethoprim, Sulfamethoxazole Drug Combination 2Tacrolimus 2Specimen Handling 2Idarubicin 2Decitabine 2Daunorubicin 2Clofarabine 2Busulfan 2Bone Marrow Transplantation 2quizartinib 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Biphenotypic, Acute × revumenib × Clear all
NCT04065399 2026-03-18

AUGMENT-101

Syndax Pharmaceuticals

Phase 1/2 Recruiting
447 enrolled 2 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07356154 2026-01-21

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡